2-氨基-4-三氟甲基-6-甲基嘧啶 | 5734-63-4

• 物质功能分类: 医药中间体 - 杂环化合物 - 嘧啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 2-氨基-4-三氟甲基-6-甲基嘧啶
• 中文别名: 2-氨基-4-甲基-6-三氟甲基嘧啶
• 英文名称: 2-amino-4-(trifluoromethyl)-6-methylpyrimidine
• 英文别名: 2-amino-6-methyl-4-(trifluoromethyl)pyrimidine；4-methyl-6-trifluoromethylpyrimidin-2-ylamine；4-methyl-6-trifluoromethyl-pyrimidin-2-amine；4-trifluoromethyl-6-methyl-2-aminopyrimidine；4-methyl-6-trifluoromethyl-pyrimidin-2-ylamine；2-amino-4-trifluoromethyl-6-methylpyrimidine；4-Methyl-6-(trifluoromethyl)pyrimidin-2-amine
• CAS: 5734-63-4
• 化学式: C₆H₆F₃N₃
• mdl: MFCD00160470
• 分子量: 177.129
• InChiKey: CNTCLEOUAMWZGS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  51.8
• 氢给体数：
  1
• 氢受体数：
  6

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  T
• 安全说明：
  S45
• 危险类别码：
  R25
• WGK Germany：
  3
• 海关编码：
  2933599090
• 危险标志：
  GHS06
• 危险性描述：
  H301
• 危险性防范说明：
  P301 + P310
• 包装等级：
  III
• 危险类别：
  6.1
• 危险品运输编号：
  2811
• 储存条件：
  存储条件为：2-8°C，避光，惰性气体环境中。

反应信息

• 作为反应物：
  描述：

  2-氨基-4-三氟甲基-6-甲基嘧啶 在 盐酸 、 sodium nitrite 作用下， 以 水 为溶剂， 反应 0.5h， 以33%的产率得到2-氯-4-甲基-6-(三氟甲基)嘧啶
  参考文献：
  名称：

  氟化2-氨基-嘧啶-N-氧化物的一锅法合成。1,2,4-恶二唑四原子侧链重排中的竞争途径

  摘要：

  通过使3-氨基-5-甲基-1,2,4-恶二唑与三氟甲基-β-二酮在高氯酸存在下反应，然后水解，合成了三氟甲基化的2-氨基-嘧啶N-氧化物。在这种环到环的转化中，最初形成（单）的1,2,4-恶二唑-嘧啶鎓盐，然后在恶二唑部分开环。从反应混合物中分离出2-（羟氨基）-嘧啶证明存在竞争途径，其中恶二唑的N（4）氮参与区域异构的嘧啶鎓盐的形成。讨论了三氟甲基对产物分布的影响。通过X射线分析，两种不同N的晶体结构已经明确地确定了-氧化物区域异构体。

  DOI：

  10.1016/j.tet.2005.10.071
• 作为产物：
  描述：

  4-trifluoromethyl-6-methyl-2-acetylaminopyrimidine 在 sodium hydroxide 作用下， 以 乙醇 为溶剂， 反应 20.0h， 以70%的产率得到2-氨基-4-三氟甲基-6-甲基嘧啶
  参考文献：
  名称：

  One‐pot synthesis of N ² ‐aminoprotected 6‐substituted and cycloalka[ d ] 4‐trifluoromethyl‐2‐acetylaminopyrimidines

  摘要：

  Abstractmagnified imageThe one‐pot synthesis of a novel series of amino‐protected 6‐alkyl‐, 6‐aryl‐, 6‐heteroaryl‐ and 5,6‐fused‐cycloalkane 4‐trifluoromethyl‐2‐acetylaminopyrimidines, where alkyl = Me; aryl = Ph, 4‐CH3Ph, 4‐FPh, 4‐ClPh, 4‐BrPh, 4‐OCH3Ph, 4‐NO2Ph, 4,4′‐biphenyl, 1‐naphthyl; heteroaryl = 2‐thienyl, 2‐furyl and cycloalkyl = c‐C6H4, c‐C7H5 from the reaction of substituted 4‐methoxy‐1,1,1‐trifluoroalk‐3‐en‐2‐ones with 1‐acetylguanidine in acetonitrile or propan‐2‐ol as solvent, is reported. The acetylamino group of 2‐acetylaminopyrimidines was hydrolyzed under three different conditions to afford the corresponding free 2‐aminopyrimidines.

  DOI：

  10.1002/jhet.5570450228

文献信息

• Phenylalanine derivatives
  申请人：Celltech Therapeutics Limited

  公开号：US06348463B1

  公开（公告）日：2002-02-19

  Phenylalanine derivatives of formula (1) are described: in which: Ar1 is an aromatic or heteroaromatic group; L1 is a linker atom or group; R is a carboxylic acid or a derivative thereof; Ar2 is an optionally substituted aromatic or heteroaromatic group; and the salts, solvates, hydrates and N-oxides thereof. The compounds are able to inhibit the binding of &agr;4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.

  公式（1）的苯丙氨酸衍生物如下所述： 其中： Ar1是芳香族或杂环芳基； L1是连接原子或基团； R是羧酸或其衍生物； Ar2是可选择取代的芳香族或杂环芳基； 以及它们的盐、溶剂合物、水合物和N-氧化物。 这些化合物能够抑制α4整合素与其配体的结合，并可用于预防和治疗免疫或炎症性疾病。
• Synthesis of fluorinated heterocycles
  作者：Joseph C. Sloop、Carl L. Bumgardner、W.David Loehle

  DOI：10.1016/s0022-1139(02)00221-x

  日期：2002.12

  Selected 1,3-diketones having a trifluoromethyl group and/or a fluorine in the 2-position were condensed with aromatic hydrazines, hydroxylamine, urea, thiourea, guanidine, and substituted anilines producing pyrazoles, isoxazoles, pyrimidines, and quinolines, respectively, in yields ranging from 27 to 87%.

  将选定的在2位具有三氟甲基和/或氟的1,3-二酮与芳族肼，羟胺，尿素，硫脲，胍和取代的苯胺缩合，分别生成吡唑，异恶唑，嘧啶和喹啉。产率从27％到87％。
• HETEROCYCLIC AMINE DERIVATIVES
  申请人：Galley Guido

  公开号：US20120245172A1

  公开（公告）日：2012-09-27

  The present invention relates to compounds of formula I wherein A, B, X, Y, Ar, R 1 , R 2 , R′, m and n are as defined herein and to pharmaceutical active acid addition salts thereof. Compounds of formula I have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1. The compounds can be used for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson's disease, neurodegenerative disorders such as Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.

  本发明涉及式I的化合物，其中A、B、X、Y、Ar、R1、R2、R′、m和n的定义如本文所述，并且涉及其药用活性酸盐。式I的化合物对痕量胺相关受体（TAARs）具有良好的亲和力，特别是对TAAR1。这些化合物可用于治疗抑郁症、焦虑障碍、双相情感障碍、注意力缺陷多动障碍（ADHD）、与压力相关的障碍、精神分裂症等精神障碍、帕金森病等神经系统疾病、阿尔茨海默病等神经退行性疾病、癫痫、偏头痛、高血压、物质滥用、以及代谢障碍如进食障碍、糖尿病、糖尿病并发症、肥胖症、脂质代谢异常、能量消耗和吸收障碍、体温稳态障碍、睡眠和昼夜节律障碍、以及心血管疾病。
• [EN] HETEROCYCLIC AMINE DERIVATIVES<br/>[FR] DÉRIVÉS D'AMINES HÉTÉROCYCLIQUES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2012126922A1

  公开（公告）日：2012-09-27

  The present invention relates to compounds of formula (I) wherein R1 is hydrogen, lower alkyl, halogen, lower alkyl substituted by halogen, lower alkoxy, lower alkoxy substituted by halogen, cyano, nitro, C3-6-cycloalkyl, -CH2-C3-6-cycloalkyl, -O-CH2-C3-6-cycloalkyl, -O-(CH2)2-O-lower alkyl, S(O)2CH3, SF5, -C(O)NH-lower alkyl, phenyl, -O-pyrimidinyl, optionally substituted by lower alkoxy substituted by halogen, or is benzyl, oxetanyl or furanyl; m Ar is aryl or heteroaryl, selected from the group consisting of phenyl, naphthyl, pyrimidinyl, pyridinyl, benzothiazolyl, quinolinyl, quinazolinyl, benzo[d][1.3]dioxolyl, 5,6,7,8- tetrahydro-quinazolinyl, pyrazolyl, pyrazinyl, pyridazinyl, or 1,3,4-oxadiazolyl; Y is a bond, -CH2-, -CH2CH2-, -CH(CF3)- or -CH(CH3)-; R2 is hydrogen or lower alkyl; A is CR or N; and R is hydrogen, cyano, halogen or lower alkyl; R' is hydrogen or halogen; with the proviso that when R' is halogen, then A is CH; B is CH or N; n is 0, 1 or 2; X is a bond, -CH2- or -O-; pharmaceutical active acid addition salts thereof. It has now been found that the compounds of formula I have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1. The compounds may be used for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson's disease, neurodegenerative disorders such as Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.

  本发明涉及以下式（I）的化合物，其中R1是氢、低碳基、卤素、被卤素取代的低碳基、低烷氧基、被卤素取代的低烷氧基、氰基、硝基、C3-6环烷基、-CH2-C3-6环烷基、-O-CH2-C3-6环烷基、-O-(CH2)2-O-低碳基、S(O)2CH3、SF5、-C(O)NH-低碳基、苯基、-O-嘧啶基，或是被低烷氧基取代的被卤素取代的苯基、或者是苄基、氧杂环戊二烯基或呋喃基；m Ar是芳基或杂芳基，选自苯基、萘基、嘧啶基、吡啶基、苯并噻唑基、喹啉基、喹唑啉基、苯并[d][1.3]二噁基、5,6,7,8-四氢喹唑啉基、吡唑基、吡嗪基、吡啶啉基或1,3,4-噁二唑基；Y是键、-CH2-、-CH2CH2-、-CH(CF3)-或-CH(CH3)-；R2是氢或低碳基；A是CR或N；R是氢、氰基、卤素或低碳基；R'是氢或卤素；但是如果R'是卤素，则A是CH；B是CH或N；n是0、1或2；X是键、-CH2-或-O-；以及它们的药用活性酸盐。现已发现，式I的化合物对痕量胺相关受体（TAARs）具有良好的亲和力，特别是对TAAR1。这些化合物可用于治疗抑郁症、焦虑障碍、躁郁症、注意力缺陷多动障碍（ADHD）、与压力有关的障碍、精神分裂症等精神障碍、帕金森病等神经系统疾病、阿尔茨海默病等神经退行性疾病、癫痫、偏头痛、高血压、物质滥用以及代谢障碍，如进食障碍、糖尿病、糖尿病并发症、肥胖症、脂质代谢异常、能量消耗和吸收障碍、体温稳态障碍、睡眠和昼夜节律障碍，以及心血管疾病。
• Haloacetylated enol ethers.<b>8</b>[12]. Reaction of β-alkoxyvinyl trihalomethyl ketones with guanidine hydrochloride. Synthesis of 4-trihalomethyl-2-aminopyrimidines
  作者：Nilo Zanatta、Maria de F. M. Cortelini、Marcos J. S. Carpes、Helio G. Bonacorso、Marcos A. P. Martins

  DOI：10.1002/jhet.5570340226

  日期：1997.3

  In this work the results of the reaction of β-alkoxyvinyl trihalomethyl ketones 1, 2a-e, with guanidine hydrochloride are reported. Depending on the ketone 1 or 2 and the conditions under which the reactions were carried out, 4-trihalomethyl-2-amino pyrimidines, β-alkoxyvinyl carboxylic acids, or β-acetal carboxylic esters were obtained.

  在这项工作中，报道了β-烷氧基乙烯基三卤代甲基酮1、2a-e与盐酸胍的反应结果。根据酮1或2和进行反应的条件，获得4-三卤甲基-2-氨基嘧啶，β-烷氧基乙烯基羧酸或β-缩醛羧酸酯。